James Davis, MD

Assistant Professor of Medicine
Member of the Duke Cancer Institute
Email address james.m.davis@duke.edu

Dr. James Davis is a practicing physician of Internal Medicine, and serves as the Medical Director for Duke Center for Smoking Cessation, Director of the Duke Smoking Cessation Program and Co-Director of the Duke-UNC Tobacco Treatment Specialist Credentialing Program.  His research focuses on development of new pharmaceutical treatments for smoking cessation.  He is principal investigator on several trials including a study on “adaptive” smoking cessation and several trials on new medications for smoking cessation. The new medications leverage more novel neurobiological mechanisms - NMDA receptor antagonism, nicotinic receptor antagonism, which impact addiction-based learning and cue response. Additionally, Dr. Davis serves as co-investigator on trials on lung cancer screening, e-cigarettes, minor nicotine alkaloids, imaging trials, lung function trials and others. Dr. Davis leads the Duke Smoke-Free Policy Initiative, is co-author on a national  tobacco dependence treatment guideline, and provides training in tobacco dependence treatment for the Duke School of Medicine, Duke Internal Medicine, Family Practice and Psychiatry residency programs. 

Education and Training

  • Internal Medicine Residency, Mayo Clinic, 1997 - 2000
  • M.D., Southern Illinois University School of Medicine, 1997

Publications

Davis, James M., Maggie C. Anderson, Kristin A. Stankevitz, and Alison R. Manley. “Providing premedical students with quality clinical and research experience: the Tobacco Science Scholars Program..” Wmj 112, no. 5 (October 2013): 195–98.

PMID
24734413
Scholars@Duke

Davis, James M., David M. Mills, Kristin A. Stankevitz, Alison R. Manley, Matthew R. Majeskie, and Stevens S. Smith. “Pilot randomized trial on mindfulness training for smokers in young adult binge drinkers..” Bmc Complement Altern Med 13 (September 3, 2013). https://doi.org/10.1186/1472-6882-13-215.

PMID
24006963
Full Text

Goldberg, Simon B., James M. Davis, and William T. Hoyt. “The role of therapeutic alliance in mindfulness interventions: therapeutic alliance in mindfulness training for smokers..” J Clin Psychol 69, no. 9 (September 2013): 936–50. https://doi.org/10.1002/jclp.21973.

PMID
23775222
Full Text

Gloria, Rebecca, Lisa Angelos, Hillary S. Schaefer, James M. Davis, Matthew Majeskie, Burke S. Richmond, John J. Curtin, Richard J. Davidson, and Timothy B. Baker. “An fMRI investigation of the impact of withdrawal on regional brain activity during nicotine anticipation..” Psychophysiology 46, no. 4 (July 2009): 681–93. https://doi.org/10.1111/j.1469-8986.2009.00823.x.

PMID
19490513
Full Text

Fleming, Michael F., James Davis, and Steven D. Passik. “Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients..” Pain Med 9, no. 8 (November 2008): 1098–1106. https://doi.org/10.1111/j.1526-4637.2008.00491.x.

PMID
18721174
Full Text

Slagter, Heleen A., Antoine Lutz, Lawrence L. Greischar, Andrew D. Francis, Sander Nieuwenhuis, James M. Davis, and Richard J. Davidson. “Mental training affects distribution of limited brain resources..” Plos Biol 5, no. 6 (June 2007). https://doi.org/10.1371/journal.pbio.0050138.

PMID
17488185
Full Text

Davis, James M., Michael F. Fleming, Katherine A. Bonus, and Timothy B. Baker. “A pilot study on mindfulness based stress reduction for smokers..” Bmc Complement Altern Med 7 (January 25, 2007). https://doi.org/10.1186/1472-6882-7-2.

PMID
17254362
Full Text

Davis, J. M. “Optimizing Clinical Trial Enrollment Methods Through "Goal Programming".” Applied Clinical Trials: Your Peer Reviewed Guide to Global Clinical Trials Management, n.d., 46–50.

Scholars@Duke

Pages